Spinal Cord Stimulation
Spinal cord stimulation (SCS) is an FDA-approved, implantable neuromodulation therapy that delivers targeted electrical pulses to the dorsal columns of the spinal cord — interrupting chronic pain signals before they reach the brain. It is a reversible, non-opioid solution for failed back surgery syndrome, CRPS, and refractory neuropathic pain, with a 5–7 day trial period that lets patients confirm ≥50% pain reduction before permanent implantation.
Spinal cord stimulation is an advanced, FDA-approved neuromodulation therapy for patients with chronic pain that has not responded to medications, injections, or prior surgery. A small implantable device delivers programmable electrical pulses directly to the spinal cord — modulating pain signals at their source before they reach the brain. What sets SCS apart is its trial-first approach: every patient completes a 5–7 day external trial to confirm at least 50% pain reduction before a permanent device is implanted. The system is fully reversible, wirelessly programmable, and available in multiple waveform configurations — including burst and high-frequency (10 kHz) options that provide paresthesia-free relief. SCS is a non-opioid, non-destructive solution that restores function, reduces medication dependence, and improves quality of life for appropriately selected patients.
- Clinically proven 50%+ pain reduction in appropriately selected patients
- Eliminates or reduces opioid and non-opioid medication dependence
- Trial phase confirms effectiveness before permanent implantation
- Fully reversible — removed or reprogrammed at any time
- FDA-approved for FBSS, CRPS, and chronic radiculopathy
- Restores function, sleep quality, and overall quality of life
SCS System Features
Modern spinal cord stimulation platforms combine precision neuromodulation, adaptive waveform technology, and wireless patient control — delivering sustained, personalized pain relief without opioids or open surgery.
Targeted Dorsal Column Neuromodulation
SCS delivers precisely calibrated electrical pulses directly to the dorsal columns of the spinal cord — intercepting pain signals before they reach the brain. Depending on the waveform selected, patients experience a mild paresthesia or, with newer high-frequency and burst protocols, complete paresthesia-free relief.
Trial Stimulation Before Permanent Implant
A temporary 5–7 day external trial lets you experience real-world pain relief before committing to a permanent device. A successful trial — defined as ≥50% pain reduction — is required before proceeding. This trial-first approach is a key advantage SCS holds over most surgical interventions.
Multi-Waveform Programmable Therapy
Modern SCS platforms offer tonic, burst, and high-frequency (10 kHz) waveforms — each targeting distinct pain mechanisms. Your physician programs the optimal waveform configuration based on your specific pain pattern, anatomy, and trial response.
Wireless Patient-Controlled Programming
Patients adjust stimulation intensity, waveform, and on/off status via a wireless handheld remote or smartphone app — delivering real-time, personalized pain management that adapts to daily activity and fluctuating pain levels.
Fully Reversible & Upgradeable System
Unlike ablative procedures or spinal surgery, SCS is entirely reversible. The system can be reprogrammed, adjusted, upgraded to newer technology, or explanted at any time — making it one of the most flexible long-term pain management solutions available.
Minimally Invasive Implant Procedure
The permanent implant is placed through a minimally invasive outpatient or short-stay procedure. Thin lead wires are threaded into the epidural space and connected to a small implantable pulse generator (IPG) placed under the skin — no open spine surgery, no general anesthesia required.
Effective Across Multiple Pain Pathways
SCS modulates pain at the spinal cord level — addressing neuropathic, radicular, and complex regional pain syndromes that have not responded to medications, injections, or physical therapy. Emerging closed-loop ECAP-controlled systems further enhance precision and durability.
Individualized Long-Term Programming
Each SCS system is programmed to the patient's unique pain map, anatomy, and lifestyle — with ongoing follow-up adjustments to maintain optimal therapeutic benefit. Rechargeable IPGs now last up to 10 years, reducing the need for surgical replacement.
Benefits of Spinal Cord Stimulation
Backed by Level A clinical evidence for FBSS and peripheral ischemia, SCS consistently outperforms conventional medical management and repeat surgery — delivering durable analgesia, functional restoration, and measurable quality-of-life improvements.
- Clinically proven to reduce chronic pain by 50% or more in appropriately selected patients
- Eliminates or significantly reduces dependence on opioid and non-opioid pain medications
- Trial stimulation phase confirms effectiveness before permanent implantation
- Fully reversible — the system can be removed or reprogrammed at any time
- FDA-approved for failed back surgery syndrome, CRPS, and chronic radiculopathy
- Improves functional capacity, sleep quality, and overall quality of life
- Multiple waveform options (burst, tonic, 10 kHz) target different pain mechanisms
- Outpatient or short-stay procedure — no open spine surgery required
- Wireless patient-controlled programming adapts to daily activity and pain fluctuations
- Reduces long-term healthcare costs compared to ongoing medication management or repeat surgery
- Effective for pain unresponsive to conservative treatments or prior surgery
- Integrated into a comprehensive, multidisciplinary pain management plan
Randomized controlled trials confirm SCS achieves ≥50% pain relief in 47–48% of FBSS patients vs. 9–12% with conventional management. A 2024 network meta-analysis demonstrated novel SCS waveforms outperform medical management with superior responder rates (OR ~8.76). Long-term follow-up shows ~85% of patients sustain ≥50% pain reduction at 2 years.
SCS significantly reduces opioid and non-opioid medication dependence. Cost-utility studies show annual healthcare costs of $29,000 for SCS patients vs. $38,000 for non-stimulator controls — with higher costs in the latter attributed to greater medication use, imaging, hospitalizations, and rehabilitation services.
How Spinal Cord Stimulation Works
From initial evaluation to long-term programming, the SCS process is designed to confirm effectiveness before commitment — ensuring every patient receives a personalized, evidence-based neuromodulation solution.
Comprehensive Evaluation & Candidacy Assessment
A thorough pain evaluation reviews your history, prior treatments, diagnostic imaging, and psychological readiness. Ideal candidates have chronic pain lasting 6+ months that has not responded adequately to medications, physical therapy, or interventional procedures.
Temporary Trial Stimulation (5–7 Days)
Thin lead wires are placed in the epidural space and connected to an external pulse generator worn outside the body. You experience the therapy in your daily life for 5–7 days. A ≥50% reduction in pain confirms candidacy for permanent implantation.
Minimally Invasive Permanent Implant
Under local anesthesia and light sedation, permanent leads are positioned at the target spinal level and connected to a small IPG implanted subcutaneously. The procedure takes 1–2 hours; most patients return home the same day or the following morning.
Ongoing Programming & Optimization
Your SCS system is programmed to your unique pain map at implant and refined at follow-up visits. Wireless reprogramming adapts stimulation as your pain patterns evolve — ensuring sustained, long-term therapeutic benefit.
Spinal Cord Stimulation FAQ
Direct answers to the most frequently asked questions about SCS therapy — optimized for clarity and clinical accuracy.
Ready to Explore Spinal Cord Stimulation?
Our board-certified pain specialists will evaluate your candidacy, review your imaging, and guide you through every step — from trial to permanent implant.
Schedule Your Evaluation